Maculopathy
14
2
3
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
CRYSTALSIGHT Cohort 2.0
CRYSTALSIGHT: ''Cohort 1.5" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye Tracking
Stem Cell Ophthalmology Treatment Study II
Ozonized Oil as Dietary Supplement in Macular Degeneration
Assessment Of Diabetic Maculopathy Changes After Phacoemulsification by Using Optical Coherence Tomography
Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials
Anterior Corneal Striae in Hypotony
Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia
Research of Automated Maculopathy Screening Based on AI Techniques Using OCT Images
" En Face " OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic Antimalarials
Surgical Management of Optic Disc Pit Maculaopathy
Vision Measured by the Vimetrics CVA Compared With Chart Testing Under Similar Luminance and Contrast Conditions
Surgical Outcome of Vitrectomy for Myopic Traction Maculopathy in Highly Myopic Eyes
Optical Coherence Tomography Imaging of the Posterior Segment in High Myopia.